Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

'Excellent' TAVR outcomes during the pandemic | Mortality among stroke patients | Anticoagulation therapy & TAVR

News You Need to Know Today
'Excellent' TAVR outcomes during the pandemic | Mortality among stroke patients | Anticoagulation therapy & TAVR
Wednesday, January 20, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

TAVR in the time of COVID-19: Providers quickly adapted, delivering ‘excellent’ outcomes

Researchers compared patient outcomes from 2019 with data from the pandemic’s first four months, sharing their findings in the American Journal of Cardiology.  

READ MORE >
Hypertension patients measured their blood pressure less frequently during the early months of the COVID-19 pandemic, according to new research published in Hypertension. In addition, when those patients did measure their blood pressure, the readings were less healthy than they had been before the pandemic.
Share on Twitter Share on Facebook Share on Linkedin

TAVR in the time of COVID-19: Providers quickly adapted, delivering ‘excellent’ outcomes

Share on Twitter Share on Facebook Share on Linkedin
Hypertension patients measured their blood pressure less frequently during the early months of the COVID-19 pandemic, according to new research published in Hypertension. In addition, when those patients did measure their blood pressure, the readings were less healthy than they had been before the pandemic.
Researchers compared patient outcomes from 2019 with data from the pandemic’s first four months, sharing their findings in the American Journal of Cardiology.  
READ MORE >

What new research tells us about stroke mortality among men and women

Prior to popular belief, sex may not necessarily be an independent risk factor for stroke mortality, according to the analysis. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

What new research tells us about stroke mortality among men and women

Share on Twitter Share on Facebook Share on Linkedin
Prior to popular belief, sex may not necessarily be an independent risk factor for stroke mortality, according to the analysis. 
READ MORE >

No reason to quit: TAVR patients can continue anticoagulation therapy throughout procedure

Patients are typically told to put anticoagulation therapy on hold two to four days before they undergo TAVR. This study’s authors aimed to see if this was truly necessary.  

READ MORE >
Driven by its strategic goal to advance equity in the U.S. healthcare innovation sector, the American Medical Association (AMA) recently announced an initiative that supports leading industry stakeholders in committing to equitable health innovation opportunities targeted to improving health outcomes in historically marginalized communities. #Healthdisparities 
Share on Twitter Share on Facebook Share on Linkedin

No reason to quit: TAVR patients can continue anticoagulation therapy throughout procedure

Share on Twitter Share on Facebook Share on Linkedin
Driven by its strategic goal to advance equity in the U.S. healthcare innovation sector, the American Medical Association (AMA) recently announced an initiative that supports leading industry stakeholders in committing to equitable health innovation opportunities targeted to improving health outcomes in historically marginalized communities. #Healthdisparities 
Patients are typically told to put anticoagulation therapy on hold two to four days before they undergo TAVR. This study’s authors aimed to see if this was truly necessary.  
READ MORE >

Featured Articles

When hospitalized COVID-19 patients head home, the cardiovascular challenges continue

The research included data from more than 47,000 hospitalized COVID-19 patients. 

READ MORE >
New findings out of the University of Missouri suggests that the long-lasting impact of COVID-19 may not be quite as substantial as some researchers originally believed. The study’s authors evaluated nearly 50 different symptoms to see if they were more common up to one year after a person has been infected with COVID-19. They found, however, that this was true of just seven symptoms: heart palpitations, chest pain, shortness of breath, joint pain, hair loss, fatigue and obesity. #COVID19 #longCOVID
Share on Twitter Share on Facebook Share on Linkedin

When hospitalized COVID-19 patients head home, the cardiovascular challenges continue

Share on Twitter Share on Facebook Share on Linkedin
New findings out of the University of Missouri suggests that the long-lasting impact of COVID-19 may not be quite as substantial as some researchers originally believed. The study’s authors evaluated nearly 50 different symptoms to see if they were more common up to one year after a person has been infected with COVID-19. They found, however, that this was true of just seven symptoms: heart palpitations, chest pain, shortness of breath, joint pain, hair loss, fatigue and obesity. #COVID19 #longCOVID
The research included data from more than 47,000 hospitalized COVID-19 patients. 
READ MORE >

Empagliflozin provides additional benefits to patients with type 2 diabetes and CAD

The authors found a link between six months of empagliflozin and a reduction in extracellular volume, sharing their findings in JACC: Cardiovascular Imaging.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Empagliflozin provides additional benefits to patients with type 2 diabetes and CAD

Share on Twitter Share on Facebook Share on Linkedin
The authors found a link between six months of empagliflozin and a reduction in extracellular volume, sharing their findings in JACC: Cardiovascular Imaging.
READ MORE >

Why STEMI patients undergoing PCI should be tested for subclinical hypothyroidism

For patients undergoing PCI, subclinical hypothyroidism was associated with higher short-term and long-term mortality.

READ MORE >
family visits with doctor
Share on Twitter Share on Facebook Share on Linkedin

Why STEMI patients undergoing PCI should be tested for subclinical hypothyroidism

Share on Twitter Share on Facebook Share on Linkedin
family visits with doctor
For patients undergoing PCI, subclinical hypothyroidism was associated with higher short-term and long-term mortality.
READ MORE >

In Other News

People with diabetes open to remote digital monitoring; more concerned about intrusiveness than AI per se

One turnoff is remote food monitoring. Another is real-time feedback—whether from a live healthcare professional or an AI algorithm.

READ MORE >
Diabetes
Share on Twitter Share on Facebook Share on Linkedin

People with diabetes open to remote digital monitoring; more concerned about intrusiveness than AI per se

Share on Twitter Share on Facebook Share on Linkedin
Diabetes
One turnoff is remote food monitoring. Another is real-time feedback—whether from a live healthcare professional or an AI algorithm.
READ MORE >

Hybrid lung cancer screening program could save Medicare millions in follow-up spending

Combining the Lung CT Screening Reporting and Data System with AI-based malignancy risk scoring bolstered exam specificity up to 96%, compared to 66% when using Lung-RADS alone.

READ MORE >
lung cancer
Share on Twitter Share on Facebook Share on Linkedin

Hybrid lung cancer screening program could save Medicare millions in follow-up spending

Share on Twitter Share on Facebook Share on Linkedin
lung cancer
Combining the Lung CT Screening Reporting and Data System with AI-based malignancy risk scoring bolstered exam specificity up to 96%, compared to 66% when using Lung-RADS alone.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: Former ACC president dies | Administration questions vascular care | Is coffee bad for the heart | FFR-CT guide
New-look pacemaker uses ultrasound to stimulate the heart | Heartflow reports significant revenue growth | CCTA & CTO PCI
New FFR-CT standardization consensus document | FDA clears first tricupid surgical valve | ECG AI to detect amyloidosis
Shockwave Medical's new IVL catheter | BATMAN to the rescue | Antiplatelet drugs after PCI | FDA announces recalls
When TAVR patients require surgery later in life | Colleagues pay tribute to a cardiology powerhouse | Much more
TAVR Highlights: Self-expanding valves continue to impress | A new technique | Why implant depth matters | SAPT vs. DAPT
Recall announced after 3 injuries | Medical societies respond to government report | New-look pacemaker requires no implant

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme